Effect of phenylbutazone on insulin secretion in horses with insulin dysregulation
Autor: | Kate L. Kemp, Jazmine E. Skinner, François‐René Bertin |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2024 |
Předmět: | |
Zdroj: | Journal of Veterinary Internal Medicine, Vol 38, Iss 2, Pp 1177-1184 (2024) |
Druh dokumentu: | article |
ISSN: | 1939-1676 0891-6640 |
DOI: | 10.1111/jvim.17013 |
Popis: | Abstract Background Phenylbutazone is often prescribed to manage pain caused by hyperinsulinemia‐associated laminitis, but in diabetic people nonsteroidal anti‐inflammatory drugs increase insulin secretion and pancreatic activity. Hypothesis/Objectives Investigate the effect of phenylbutazone administration on insulin secretion in horses. It was hypothesized that phenylbutazone will increase insulin secretion in horses with insulin dysregulation (ID). Animals Sixteen light breed horses, including 7 with ID. Methods Randomized cross‐over study design. Horses underwent an oral glucose test (OGT) after 9 days of treatment with phenylbutazone (4.4 mg/kg IV q24h) or placebo (5 mL 0.9% saline). After a 10‐day washout period, horses received the alternative treatment, and a second OGT was performed. Insulin and glucose responses were compared between groups (ID or controls) and treatments using paired t test and analyses of variance with P |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |